What is preeclampsia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Introduction to Preeclampsia

Preeclampsia is a multisystem disorder of human pregnancy with a genetic predisposition, characterized by hypertension and a variety of organ failures, including malfunction of kidneys, liver, and lungs 1, 2, 3, 4, 5.

Pathophysiology

The pathophysiology of preeclampsia involves abnormal placentation, leading to the release of antiangiogenic markers, such as soluble fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (sEng), which cause endothelial dysfunction, vasoconstriction, and immune dysregulation 3, 5. This results in widespread maternal endothelial cell damage, leading to organ hypoperfusion and dysfunction 1.

Clinical Presentation

The clinical presentation of preeclampsia is highly variable, but hypertension and proteinuria are usually seen 1, 2, 3, 4, 5. The disease can affect multiple organ systems, including the kidneys, liver, lungs, and brain, and can lead to significant maternal and perinatal morbidity and mortality.

Treatment and Management

The only definitive treatment for preeclampsia is delivery of the placenta, either through induction of labor or cesarean section 1, 2, 3, 4. For women with mild preeclampsia, expectant management may be indicated to improve fetal maturity, often requiring maternal medical treatment 2. Low-dose aspirin is recommended for prophylaxis in high-risk populations 3.

Treatment Options

  • Delivery of the placenta: the only definitive treatment for preeclampsia
  • Expectant management: for women with mild preeclampsia to improve fetal maturity
  • Low-dose aspirin: for prophylaxis in high-risk populations
  • Management of high blood pressure and potential complications: according to current treatment guidelines

Dosing Information

  • Low-dose aspirin: the exact dosage is not specified in the provided evidence, but it is generally recommended to take 81-100 mg per day for prophylaxis in high-risk populations.

Differential Diagnosis and Caveats

Preeclampsia can be difficult to diagnose, as the clinical presentation is highly variable and can resemble other conditions, such as chronic hypertension or kidney disease 1, 5. A thorough medical history, physical examination, and laboratory tests are necessary to confirm the diagnosis and rule out other potential causes of hypertension and organ dysfunction.

Conclusion

Preeclampsia is a complex and multifactorial disease that requires a comprehensive understanding of its pathophysiology, clinical presentation, and treatment options. Further research is needed to clarify the underlying mechanisms and identify potential therapeutic targets for improved treatment and outcomes.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.